See also: Regulatory communications
Drug labels
See also: history of changes to adverse effects on the Propecia label
Applications and approvals
See also: How to access clinical trial data from RIAT Initiative (Restoring Invisible & Abandoned Trials).
Propecia
Propecia approval documents – Drugs@FDA
Proscar
FDA Advisory Committee meetings
Dermatologic and Ophthalmic Drugs Advisory Committee, Center for Drug Evaluation and Research, Food and Drug Administration. Meeting No. 48 regarding Propecia, sponsored by Merck. November 13, 1997. Archived
Oncologic Drugs Advisory Committee, Center for Drug Evaluation and Research, Food and Drug Administration. Meeting re: efficacy and safety of Proscar and Avodart for reducing the risk of prostate cancer on December 1, 2010. Archived